Financial Ratios

CONCORD DRUGS LTD.

NSE : NABSE : 538965ISIN CODE : INE858L01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE35.17-0.73 (-2.03 %)
PREV CLOSE ( ) 35.90
OPEN PRICE ( ) 35.01
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12183
TODAY'S LOW / HIGH ( )34.11 35.90
52 WK LOW / HIGH ( ) 25.5661.5
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.961.823.750.380.52
   CEPS(Rs)2.683.845.312.052.70
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)33.4232.4330.6126.8629.45
   Tax Rate(%)20.9329.2723.5428.087.46
Margin Ratios
   Core EBITDA Margin(%)8.479.496.276.517.61
   EBIT Margin(%)5.366.6611.123.904.23
   Pre Tax Margin(%)2.193.818.360.890.91
   PAT Margin (%)1.732.706.390.640.85
   Cash Profit Margin (%)4.865.699.053.494.41
Performance Ratios
   ROA(%)1.572.996.080.470.43
   ROE(%)2.995.7713.061.411.92
   ROCE(%)5.979.3015.696.066.17
   Asset Turnover(x)0.911.110.950.730.51
   Sales/Fixed Asset(x)1.401.661.571.661.56
   Working Capital/Sales(x)2.503.232.602.803.52
Efficiency Ratios
   Fixed Capital/Sales(x)0.720.600.640.600.64
   Receivable days139.45134.93164.08262.63454.03
   Inventory Days124.4490.89100.58124.68141.44
   Payable days77.6069.6781.08353.85644.07
Valuation Parameters
   PER(x)28.7315.957.7434.8940.66
   PCE(x)10.267.565.476.397.81
   Price/Book(x)0.820.890.950.490.71
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.800.710.750.410.54
   EV/Core EBITDA(x)9.447.3311.566.066.99
   EV/EBIT(x)14.9510.626.7110.4912.88
   EV/CE(x)0.730.740.770.360.32
   M Cap / Sales0.500.430.490.220.34
Growth Ratio
   Net Sales Growth(%)-12.9614.800.046.78-7.18
   Core EBITDA Growth(%)-23.5571.77-4.32-7.49-23.95
   EBIT Growth(%)-30.00-31.22185.58-1.60-19.42
   PAT Growth(%)-44.03-51.55899.60-19.3425.58
   EPS Growth(%)-47.46-51.55899.61-27.4725.58
Financial Stability Ratios
   Total Debt/Equity(x)0.500.580.480.410.42
   Current Ratio(x)1.981.772.221.671.24
   Quick Ratio(x)1.141.031.491.070.91
   Interest Cover(x)1.692.344.021.301.28
   Total Debt/Mcap(x)0.610.650.570.930.59

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.